Contact
Please use this form to send email to PR contact of this press release:
Regulatory Update – GSK announces submissions in the EU & US for new indications for Promacta®/Revolade®
TO:
Please use this form to send email to PR contact of this press release:
Regulatory Update – GSK announces submissions in the EU & US for new indications for Promacta®/Revolade®
TO: